Adlai Nortye Group Ltd. (NASDAQ:ANL) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Roger Sawhney Other companies: Arbutus Biopharma Corporation (Director · Since at least Aug 4, 2025); Actuate Therapeutics, Inc. (Director · Since at least May 22, 2025) | Director · Since at least Mar 18, 2026 |
| Alan Ming Lun Tse | Director · Since at least Mar 18, 2026 |
| Archie Tse | President, Head of R&D · Since at least Oct 27, 2026 |
| Baozhong Wei | Independent Director · Since at least Nov 5, 2026 |
| Christopher Liu | Head of Investor Relations and Public Relations · Since at least Nov 5, 2026 |
| Lars E. Birgerson | Director · Since at least Mar 18, 2026 |
| Ming Lun Alan Tse | Independent Director · Since at least Nov 5, 2026 |
| Nanhai He | Head of Discovery · Since at least Nov 5, 2026 |
| Ping Ji | Director · Since at least Nov 5, 2026 |
| Shaorong Liu | Independent Director · Since at least Nov 5, 2026 |
| Xiaofeng Ye | CFO · Since at least May 28, 2026 |
| Yang Lu | CEO, Director · Since at least Mar 18, 2026 |
| Zhiyong Yu | Head of Operation · Since at least Nov 5, 2026 |